These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20812148)

  • 1. The potential for caspases in drug discovery.
    MacKenzie SH; Schipper JL; Clark AC
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):568-76. PubMed ID: 20812148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of caspases.
    Häcker HG; Sisay MT; Gütschow M
    Pharmacol Ther; 2011 Nov; 132(2):180-95. PubMed ID: 21807025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Active Site Directed Tools for Studying Human Caspases.
    Poreba M; Szalek A; Kasperkiewicz P; Rut W; Salvesen GS; Drag M
    Chem Rev; 2015 Nov; 115(22):12546-629. PubMed ID: 26551511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule procaspase activators identified using fluorescence polarization.
    Vickers CJ; González-Páez GE; Umotoy JC; Cayanan-Garrett C; Brown SJ; Wolan DW
    Chembiochem; 2013 Aug; 14(12):1419-22. PubMed ID: 23836614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning on caspases with genetics and small molecules.
    Morgan CW; Julien O; Unger EK; Shah NM; Wells JA
    Methods Enzymol; 2014; 544():179-213. PubMed ID: 24974291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bifunctional allosteric site in the dimer interface of procaspase-3.
    Schipper JL; MacKenzie SH; Sharma A; Clark AC
    Biophys Chem; 2011 Nov; 159(1):100-9. PubMed ID: 21645959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current opinion on 3-[2-[(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]- 4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid, an investigational drug targeting caspases and caspase-like proteases: the clinical trials in sight and recent anti-inflammatory advances.
    Haddad JJ
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):229-58. PubMed ID: 23859695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidomimetic toolbox for drug discovery.
    Lenci E; Trabocchi A
    Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating caspase activity: beyond the active site.
    Murray J; Renslo AR
    Curr Opin Struct Biol; 2013 Dec; 23(6):812-9. PubMed ID: 24215810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspases: potential targets for regulating cell death.
    Philchenkov A
    J Cell Mol Med; 2004; 8(4):432-44. PubMed ID: 15601572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of constrained peptidomimetic chemotypes as HIV protease inhibitors.
    Calugi C; Guarna A; Trabocchi A
    Eur J Med Chem; 2014 Sep; 84():444-53. PubMed ID: 25042102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
    Våbenø J; Haug BE; Rosenkilde MM
    Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motif mediated protein-protein interactions as drug targets.
    Corbi-Verge C; Kim PM
    Cell Commun Signal; 2016 Mar; 14():8. PubMed ID: 26936767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor.
    Barros TG; Santos JAN; de Souza BEG; Sodero ACR; de Souza AMT; da Silva DP; Rodrigues CR; Pinheiro S; Dias LRS; Abrahim-Vieira B; Puzer L; Muri EMF
    Bioorg Med Chem Lett; 2017 Jan; 27(2):314-318. PubMed ID: 27914800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
    Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L
    Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule activators of a proenzyme.
    Wolan DW; Zorn JA; Gray DC; Wells JA
    Science; 2009 Nov; 326(5954):853-8. PubMed ID: 19892984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspases as therapeutic targets.
    Howley B; Fearnhead HO
    J Cell Mol Med; 2008; 12(5A):1502-16. PubMed ID: 18298652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of an allosteric site in the caspases.
    Hardy JA; Lam J; Nguyen JT; O'Brien T; Wells JA
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12461-6. PubMed ID: 15314233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring small molecules for an allosteric site on procaspase-6.
    Murray J; Giannetti AM; Steffek M; Gibbons P; Hearn BR; Cohen F; Tam C; Pozniak C; Bravo B; Lewcock J; Jaishankar P; Ly CQ; Zhao X; Tang Y; Chugha P; Arkin MR; Flygare J; Renslo AR
    ChemMedChem; 2014 Jan; 9(1):73-7, 2. PubMed ID: 24259468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.